Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ·Healthcare·Biotechnology
$21.10
+0.46%
Mkt Cap $2.06B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $64.30M | $68.73M | +6.88% | -$0.58 | -$0.78 | -33.55% | — | — |
| Q4 2025 Nov 3, 2025 | $63.34M | $45.87M | -27.58% | -$0.74 | -$0.70 | +5.41% | — | — |
| Q3 2025 Aug 4, 2025 | $45.65M | $37.96M | -16.85% | -$1.00 | -$0.83 | +17.00% | — | — |
| Q2 2025 May 5, 2025 | $18.55M | $20.04M | +8.06% | -$1.04 | -$0.98 | +5.77% | — | — |
| Q1 2025 Mar 3, 2025 | $12.79M | $7.68M | -39.93% | -$1.08 | -$1.10 | -1.85% | — | — |
| Q4 2024 Nov 5, 2024 | $115.23M | $12.50M | -89.15% | -$1.13 | -$0.98 | +13.27% | — | — |
| Q3 2024 Aug 1, 2024 | — | $3.50M | — | -$0.91 | -$0.80 | +12.09% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.96 | -$0.85 | +11.46% | — | — |
| Q1 2024 Feb 27, 2024 | — | $536.00K | — | -$0.99 | -$1.00 | -1.01% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.80 | -$0.73 | +8.75% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.73 | -$0.64 | +12.33% | — | — |
| Q2 2023 May 8, 2023 | $430.00K | — | — | -$0.61 | -$0.59 | +3.28% | — | — |
| Q1 2023 Feb 28, 2023 | $1.33M | — | — | -$0.64 | -$0.62 | +3.13% | — | — |
| Q4 2022 Nov 3, 2022 | $750.00K | — | — | -$0.65 | -$0.58 | +10.77% | — | — |
| Q3 2022 Aug 8, 2022 | $1.38M | — | — | -$0.65 | -$0.62 | +4.62% | — | — |
| Q2 2022 May 9, 2022 | $2.56M | — | — | -$0.63 | -$0.63 | +0.00% | — | — |
| Q1 2022 Mar 1, 2022 | $6.29M | $126.58M | +1911.80% | $0.28 | $1.81 | +546.43% | — | — |
| Q4 2021 Nov 15, 2021 | $11.98M | $12.38M | +3.25% | -$0.64 | -$0.40 | +37.50% | — | — |
| Q3 2021 Aug 9, 2021 | $379.00K | $379.00K | +0.00% | -$0.74 | -$0.44 | +40.54% | — | — |
| Q2 2021 May 11, 2021 | $220.00K | $379.00K | +72.27% | -$0.64 | -$0.54 | +15.62% | — | — |